CORONARY INTERVENTIONS

A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial

EuroIntervention 2018;14:86-93 published online March 2018. DOI: 10.4244/EIJ-D-17-00890

Valeria Paradies1, MD; Ori Ben-Yehuda2, MD; Michael Jonas3, MD; Shmuel Banai4, MD; Andres Iñiguez5, MD; Gidon Y. Perlman6, MD; David E. Kandzari7, MD; Gregg W. Stone2, MD; Pieter C. Smits1*, MD, PhD

1. Maasstad Hospital, Rotterdam, the Netherlands; 2. Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA; 3. Kaplan Medical Center, Rechovot, Israel; 4. Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 5. Ho

Aims: The aim of this study was to evaluate the efficacy and safety of the BioNIR stent compared with the Resolute Integrity stent for the treatment of coronary artery disease.

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary artery diseaseclinical researchqca

Stents and scaffolds

Share on Facebook Share on Twitter Share on Linkedin

Latest news